Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of AVE1625 in Abdominally Obese Patients With Atherogenic Dyslipidemia
NCT00345410Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jun 2006
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of OPNT004 in obesity, dyslipidemia, sponsored by Sanofi. Started Jun 2006; status: completed.
02
Drugs
OPNT004
03
Conditions
obesitydyslipidemia
Beyond the preview
Go deeper on NCT00345410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00345410.